Category · 10 peptides
Growth-hormone & performance peptides
Secretagogues that nudge your own GH. Real effects on some markers — but read the fine print before you believe the before-and-afters.
They do raise GH/IGF-1
MK-677, CJC-1295 and ipamorelin measurably move hormone markers.
Body-comp claims overreach
Moving a hormone is not the same as the dramatic physique results sold online.
Side effects are real
Water retention, hunger and insulin changes are common and under-discussed.
Every Performance peptide we've ruled on
See all categories →AOD-9604 is a synthetic fragment of human growth hormone commonly researched for fat metabolism and body composition. It is not FDA-approved and is sold for laboratory research use only; the human weight-loss results were disappointing, and effects and long-term safety in people are still being studied.
CJC-1295 is a GHRH-analog peptide commonly researched for its effect on growth-hormone and IGF-1 markers. It is not FDA-approved and is sold for laboratory research use only; the physique claims made for it run well ahead of the human evidence.
A follistatin isoform commonly researched for myostatin inhibition and muscle growth in animals; human evidence is extremely limited.
Potent ghrelin-receptor GH releaser — moves markers, but raises cortisol, prolactin, and appetite.
Ghrelin-receptor GH releaser best known for a strong appetite surge; moves markers but human outcome data is missing.
One of the most potent GH-releasing peptides, with a distinctive cardiac research angle and thin human outcome data.
IGF-1 LR3 is a long-acting lab-made version of insulin-like growth factor 1 (IGF-1). It is commonly researched around muscle and growth-factor signaling, but there are no controlled human trials and it is not FDA-approved.
Ipamorelin is a small growth-hormone-secretagogue peptide commonly researched for its effect on growth-hormone release. It is not FDA-approved, is sold for laboratory research use only, and its effects in humans are still being studied.
MK-677 (ibutamoren) is an orally active growth-hormone secretagogue commonly researched for its effect on growth hormone and IGF-1 levels. It is not FDA-approved and is sold for laboratory research use only; effects and long-term safety in people are still being studied.
GHRH analog that prompts the pituitary to release its own growth hormone; the age-reversal claims outrun the human evidence.